The Results of Pancreatic Operations After the Implementation of Multidisciplinary Team Conference (MDT):

November 26, 2023 updated by: carsten palnaes hansen, Rigshospitalet, Denmark

The Results of Pancreatic Operations After the Implementation of Multidisciplinary Team Conference (MDT): A Quality Improvement Study

Background: Centralization has improved the outcome of complex operations including cancer surgery. Moreover, the implementation of multidisciplinary team conferences (MDT) has ameliorated the decision making, but the impact on patient outcome is controversial. The aim of the study was to investigate the outcome of pancreatic surgery in the setting of centralization and upfront multidisciplinary decision making.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Study is a retrospective register study from a prospective database over MDT conferences and patient outcome. End points are quality evaluation regarding postoperative complications and mortality and long-term survival of patients radically operated for pancreatic cancer.

Study Type

Observational

Enrollment (Actual)

7294

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 86 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

all gender referred to MDT all gender not referred to MDT

Description

Inclusion criteria: all gender seen at multidisciplinary team conference (MDT) Exclusion criteria: all gender not seen at MDT -

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
MDT conference
participants evaluated at MDT conference
Other: number of participants with surgical complications
observation before and after multidisplinary team conference (MDT) was implemented
Other Names:
  • number of participants surviving months
no MDT conference
participants not evaluated at MDT conference
Other: number of participants with surgical complications
observation before and after multidisplinary team conference (MDT) was implemented
Other Names:
  • number of participants surviving months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
complications following pancreatic surgery
Time Frame: 14 years
study from clinical database
14 years
survival following pancreatic surgery
Time Frame: 14 years
study from clinical database
14 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rigshospitalet, Denmark

Investigators

  • Principal Investigator: carsten hansen, DMSc, Rigshospitalet, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2010

Primary Completion (Actual)

December 31, 2016

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

January 15, 2020

First Submitted That Met QC Criteria

January 17, 2020

First Posted (Actual)

January 23, 2020

Study Record Updates

Last Update Posted (Actual)

November 30, 2023

Last Update Submitted That Met QC Criteria

November 26, 2023

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RH 2015-07, nr. 03616

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pancreatic Neoplasms

Clinical Trials on number of participants with surgical complications

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe